Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-31-05:00 | Nascent Biotech Inc. | HOLDEN LOWELL THOMAS
(CFO) |
J | Common Stock | A | 112500 | $0.18 - $0.18 | $20,756 |
| 2024-03-31-05:00 | Nascent Biotech Inc. | Carrick Sean
(President & CEO) |
J | Common Stock | A | 225000 | $0.18 - $0.18 | $41,512 |
| 2024-03-31-05:00 | Nascent Biotech Inc. | Karas Douglas John
(Director) |
J | Common Stock | A | 27100 | $0.18 - $0.18 | $4,999 |
| 2023-12-29-05:00 | Nascent Biotech Inc. | Carrick Sean
(President & CEO) |
J | Common Stock | A | 239300 | $0.17 - $0.17 | $40,681 |
| 2023-12-29-05:00 | Nascent Biotech Inc. | HOLDEN LOWELL THOMAS
(CFO) |
J | Common Stock | A | 119650 | $0.17 - $0.17 | $20,340 |
| 2023-12-29-05:00 | Nascent Biotech Inc. | Karas Douglas John
(Director) |
J | Common Stock | A | 28935 | $0.18 - $0.18 | $5,208 |
| 2023-09-29-05:00 | Nascent Biotech Inc. | Karas Douglas John
(Director) |
J | Common Stock | A | 39750 | $0.12 - $0.12 | $4,968 |
| 2023-09-29-05:00 | Nascent Biotech Inc. | HOLDEN LOWELL THOMAS
(CFO) |
J | Common Stock | A | 1386300 | $0.12 - $0.12 | $173,287 |
| 2023-09-29-05:00 | Nascent Biotech Inc. | Carrick Sean
(President & CEO) |
J | Common Stock | A | 2772600 | $0.12 - $0.12 | $346,575 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |